ask="70.42"
ask_size="500"
average_daily_volume="612130"
bid="N/A"
bid_size="N/A"
book_value="9.90"
change="-1.76"
change_from_200_day_moving_average="19.00"
change_from_50_day_moving_average="12.02"
change_from_52_week_high="-4.12"
change_From_52_week_low="40.58"
change_in_percent="-2.56%"
close="66.86"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.75"
ebitda="-159.88M"
eps_estimate_current_year="-6.79"
eps_estimate_next_quarter="-1.67"
eps_estimate_next_year="-6.00"
ex_dividend_date="N/A"
float_shares="33738000"
high="70.14"
high_52_weeks="70.98"
last_trade_date="3/3/2017"
last_trade_price="66.86"
last_trade_size="21777"
last_trade_time="4:00pm"
low="66.22"
low_52_weeks="26.28"
market_capitalization="2.49B"
moving_average_200_day="47.86"
moving_average_50_day="54.84"
name="Sage Therapeutics
Inc."
notes="N/A"
one_year_target_price="82.00"
open="68.38"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+39.69%"
percent_change_from_50_day_moving_average="+21.92%"
percent_change_from_52_week_high="-5.80%"
percent_change_from_52_week_low="+154.41%"
previous_close="68.62"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.93"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="37270000"
short_ratio="8.74"
stock_exchange="NGM"
symbol="SAGE"
volume="642406"
weeks_range_52="26.28 - 70.98"
